BIBLIOGRAFÍA

1. NATIONAL INSTITUTES OF HEALTH. Consensus development conference statement. June 10-12,2002

2. Alter MJ, Kruszon-Moran D,Nainan O et al.The prevalence of Hepatitis C virus in the United States.N Eng J Med l999;341:556-562

3. Bernstein D. Diagnosis and management of Hepatitis C.Medscape from web MD. Sep 2002

4. Leung N. Management of viral Hepatitis C. Quadrennial review. J Gastroent Hep 2002, 17: 5147-5155

5. Booth JCL, Grady JD, Neuberger J. Clinical guidelines on the management of Hepatitis C. Gut 2001; 49 (Supp 1):1-12

6. Romeo C, Colombo M, Rumi M et al. Lack of association between type of Hepatitis C virus, serum load and severity of liver disease. J Viral Hep 1996; 3:183-190

7. Mc Guiness PH, Bishop GD, Painter DM et al. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C .Hepatology 1996; 23: 676-687

8. Roudot-Thoraval F, Bastie A, Pawlostsky JM, Dhumeaux D and the Study group for the prevalence and epidemiology of hepatitis C virus. Epidemiological factors affecting the severity of hepatitis C virus related Liver disease: A French survey of 6664 patients. Hepatology 1997; 26: 485-490

9. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet 1997, 349:825-832

10. Minuk GY.The influence of host factors on the natural history of chronic hepatitis C viral infections. J Viral Hep 1999; 6: 271-276

11. Wiley TE, Brown J, Chau J. Hepatitis C infection in African-American.its natural history and histological progression. A m J Gastroenterol 2002; 97: 520-522

12. Tong MJ, El-Farra NJ, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C . N Eng J Med 1995; 332.1463-1466

13. Deuffic S, Buffat L, Poynard T,Valleron AJ. Modeling the hepatitis C virus epidemic in France.Hepatology 1999;29:1596-1601

14. Conte D. Age at infection influences outcome of Hepatitis C. Blood 2002;99:4588-4591

15. Lagging LM, Wertin J, Svensson E et al.Liver fibrosis progression in HCV infected patients.Liver 2002; 22(29): 136-44

16. Hamada H,Yatsuhashi H, Yano K et al.Impact of aging on the development of hepatocelular carcinoma in patients with post-transfusion chronic hepatitis C. Cancer 2002 jul 15;95(2): 331-9

17. Danta M,Dare GJ,Hennesy L, et al. Factors associated with severity of hepatic fibrosis in people with chronic Hepatitis C infection.Med J Aust 2002;177(5) : 240-5

18. Coll S, Galeras JA, Rivera M et al. Factors associated with histological severity in hepatitis C .Biennal meeting of IASL 2002 Abstract 5374

19. Power JP, Lawler E,Davidson F et al. Hepatitis C viraemia in recipients of Irish intravenous anti-D inmunoglobulin(letter).Lancet 1994,344: 116-1167

20. Diterman S, Roggendorf M, Durkop J et al. Long term persistence of hepatitis C virus antibodies in single source outbreak . J Hepatol 1991;13:323-327

21. Yamakawa Y, Sata M, Suzuki H et al. Higher elimination rate of hepatitis C virus among women .J Viral Hep 1996,3:317-321

22. Gerlach TJ, Zachoval R, Gruener N et al. Acute Hepatitis C .Natural course and response to antiviral treatment.Hepatology 2001; 341A 

23. Seef LB. Natural history of chronic hepatitis C. Hepatology 2002;36: S35-46

24. Cramp ME, Crucci P, Underhill J et al.Association between HLA class II genotype and spontaneous clearence of hepatitis C viraemia. J Hepatol 1998;29:207-213

25. Kryczka W, Brojer E, Kalinska A et al. DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C. Med Sci Monit 2001; 7 suppl 1:217-20

26. Hue S, Cacoub P, Renou C et al. Leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus related liver disease. J Infect Dis 2002; 186(1): 106-109

27. Renou C, Halfin P,Pol S et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut 2002;51(4): 585-90

28. Simo R, Hernández C, Genesca J et al . High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996;19:998-1000

29. Mehta SH, Brancati FL, Sulkowsky MS et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Int Med 2000 ;133:133:592-599

30. Monto A, Alonzo J Watson J et al. Steatosis in chronic hepatitis C .relative contribution of obesity, diabetes mellitus and alcohol.Hepatology 2002; 36(3):729-36

31. Ruhl C, Everhart J. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in USA.Gastroenterology 2003;124(1):71-79

32. Patton H, Behling C, Patel K et al. Body mass index,HCV genotype 3,and HCV RNA levels are associated with steatosis severity in patients with chronic hepatitis C.Hepatology 2002; 36:265A(Abstract 408) 

33. Johnson J, Hickman IJ, Clouston AD, et al. Fibrosis in chronic hepatitis C .Hepatology 2002; 36:272A(Abstract 436)

34. Adinolfi LE, Gambardella M, Andreana A et al.Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.Hepatology 2001; 33:1358-64

35. Heathcote J. Weight issues in hepatitis C.Gut 2002; 51: 7-8

36. Westin J, Nordlinder H, Lagging M. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype3 infected patients. Journal Hepatol 2002; 37(6): 837-842

37. Patton HM, Behling C, Patel K, et al.Steatosis decreases significantly following succesful antiviral treatment for chronic hepatitis C infection.Hepatology 2002;36.280A(Abstract 470)

38. Hickman IJ, Clouston AD, Macdonald GA et al. Effect of weight reduction on liver histology and biochemestry in patients with chronic hepatitis C .Gut 2002;51.89-94

39. Ortiz V, Berenguer M, Rayon J et al.Contribution of obesity to hepatitis C related fibrosis progression. Am J Gastroenterol 2002; 97(9):2408-2414

40. Mitwally M,Zein C, Zein N. High body mass index is associated with advanced hepatic fibrosis in patients with chronic hepatitis C .Biennal meeting of IASL April 2002: Abstract 5515

41. Bonkovsky HL.Therapy of hepatitis C: Other options.Hepatology 1997;26(suppl 1):143S-151S

42. BonkovskyHL, BannerBE, RothmanAL. Iron and chronic viral hepatitis.Hepatology 1997;25 :759-768

43. Arber N, Konikoff FM, Moshkowitz M et al.Increased serum iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases.Dig Dis Sci 1994;39:2656-2659

44. Olmyk JK, Reddy KR, Di Bisceglie AM et al. Hepatic iron concentrations a predictor of response to alpha interpheron therapy in chronic HCV.Gastroenterology 1995;108: 1104-1109 

45. Smith BC, Girve J, Guzael MA et al.Heterozigosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C Hepatology 1998;27: 1693-1699

46. Diwakaran H,Befeler A, Briton R et al.Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol 2002;36 (5):687-691

47. Bonkovsky H,Troy N,Mc Neal K et al. Iron and HFE or TfR 1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 2002; 37(6): 848-854 

48. Fargion S, Francazani AL, Romini A et al. Hepatitis C .Am J Gastroenterol 2002,97(5): 1204-1210 

49. VanThielDH, StauberR, Cavalier JS, Francavilla A. Hepatic regeneration:effects of age, sex, hormone status, prolactin and cyclosporine. Dig Dis Sc 1991 ; 36: 1309-1312

50. Du Bois DB, Gretch D, De La Rosa C et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender- related differences in viral load. Am J Kidney Dis 1994; 24. 795-801

51. Serfaty L, Chazouilleres O, Poujol-Robert A et al.Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case control study.Hepatology 1997; 26:776-779

52. Serfaty L,Poujol-Robert A, Carbonell W et al.Effect of interactions between steatosis and alcohol intake on liver fibrosis progression in chronic hepatits C Am J Gastroenterol 2002;97 (7). 1807-1812

53. Wiley TE, Mc Carthy M,Breidi L et al.Impact of alcohol in the histological and clinical progression of hepatitis C infection.Hepatology 1998;28: 805-809

54. Sachithanandan S, Kay E, Leader M, Fielding JF. The effect of light drinking on HCV liver disease:The jury is still out.Biomed Pharmacotherap 1997; 51:295-297

55. Harris H, Ramsay M,Andrews N, Eldridge K. Clinical course of hepatitis C virus during the just decade of infection:cohort study. BMJ 2002; 324:450

56. Gao B. Interaction of alcohol and hepatitis viral proteins:implication in synergistic affect of alcohol drinking and viral hepatitis on liver injury.Alcohol 2002;27(1): 69-72

57. Barve SS, Kelkar SU, Gobejishvilli L, et al .Mechanism of alcohol-mediated CD4+T lymphocyte death:relevance to HIV and HCV pathogenesis. Front Biosci 2002 Jul 1;7:1689-1696

58. Vento S,Cainelli F. Does hepatitis C virus cause severe liver disease only in people who drink alcohol?. Lancet Infect Dis 2002; 2(5): 303-9

59. Sartori M, Mottaran E, Rigaminoti C,et al.Moderate alcohol imtake increase oxidative stress in patients with chronic hepatitis C.Hepatology 2002; 36:385A(Abstract 887)

60. Boyer N, Marcelino P. Pathogenesis.diagnosis and management of hepatitis C. J Hepatol 2000; 32 Suppl 1:98-112

61. Serfaty L,Poujol-Robert A,C arbonell N, et al.Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C . Am J Gastroenterol 2002;97 (7) 1807-12

62. Vento S, Garafano T,Renzini C ,et al.Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Eng J Med 1998; 338(5):286-90

63. Sagnelli E,Coppola N, Scolastico C, et al. Virological and clinical expressions of reciprocal inhibitory effect of hepatitis B,C and Delta viruses in patients with chronic hepatitis.Hepatology 2000; 32(5);1106-10 

64. Sagnelli E, Coppola N, Messina V et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.Hepatology 2002;36(5): 1285-98 

65. Kew MC,Yu MC, Kedda MA, et al.The relative roles of hepatitis B and C viruses in the etiology of hepatocelular carcinoma in southern African blacks.Gastroenterology 1997; 112(1): 184-7

66. Bonacini M, Puoti M. Hepatitis in patients with human inmunodeficiency virus infection: diagnosis, natural history, metanalysis of sexual and vertical transmission and therapeutic issues. Arch Inter Med 2000;160 (22): 3365-73

67. Rockstroh JK, Woitas RP, Spengler U. Human inmunodeficiency virus and hepatitis C virus coinfection.Eur J Med Res 1998; 3: 269-277

68. Thomas DL, Shih JW, Alter HJ,et al.Effect of human inmunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174: 690-695

69. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut 2002; 51: 601-608

70. Soto B, Sanchez Quijano A, Rodrigo L, et al. Human inmunodeficiency virus infection modifies the natural history of chronic parenterally –acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26: 1-5 

71. Di Martino V, Caravallaro L,Ezeufis J ,et al.Impact of HIV coinfection on the age and the cause of death in patients with HCV cirrhosis. Annual meeting of AASLD, Nov 2001. Abstract 1095

72. Rodriguez-Torres M, Rodriguez SF. Severity of liver disease in hispanic patients co infected with HCV-HIV. Annual meeting of AASLD. Nov 2001. Abstract 229

73. Tokita H, Murai S, Kamitsukasa H et al. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Vir 2002; 67(4): 501-509

74. Chiba T, Matsuzaki Y, Abei M et al. The role of previous Hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocelular carcinoma. Am J Gastroenterol 1996; 91: 1195-1203

75. Wang CS, Wang ST, Chang TT, et al. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162(7): 811-5

76. Hézode C, Lonjon I, Roudot-Thoraval F, et al.Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52:126-129